![Heather Behanna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 19 617 $ au 31/08/2026
Heather Behanna currently works at Entasis Therapeutics Holdings, Inc., as Independent Director from 2017, Design Therapeutics, Inc., as Independent Director from 2021, GSK Equity Investments Ltd., as Principal from 2019, Iolyx Therapeutics, Inc, as Chief Business Officer from 2023, and SR One Capital Management LP, as Principal from 2019.
Dr. Behanna also formerly worked at Dren Bio, Inc., as Director, Second Genome, Inc., as Director from 2020 to 2022, Entasis Therapeutics, Inc., as Independent Director from 2017 to 2022, Wedbush Securities, Inc., as Analyst from 2014 to 2017, Citizens JMP Securities LLC, as Research Associate from 2010 to 2014, Sofinnova Investments, Inc., as Principal from 2017 to 2018, Northwestern University, as Principal, Astellas Research Institute of America LLC, as Principal, and Sofinnova Ventures, as Principal.
Dr. Behanna received her doctorate degree from Northwestern University, undergraduate degree from Tufts University, and graduate degree from Weizmann Institute of Science.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/06/2026 | 1 300 ( 0% ) | 19 617 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ENTASIS THERAPEUTICS HOLDINGS INC. | Directeur/Membre du Conseil | 01/08/2017 |
| DESIGN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/06/2021 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 01/09/2019 |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 01/04/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Directeur/Membre du Conseil | 01/12/2022 |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Directeur/Membre du Conseil | 01/07/2022 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | 01/11/2018 |
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Analyst-Equity | 01/01/2017 |
JMP Securities LLC
 JMP Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/06/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 15 |
|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
JMP Securities LLC
JMP Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Research Institute of America LLC
 Astellas Research Institute of America LLC Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical research & development company | Commercial Services |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Health Technology |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
Design Therapeutics, Inc.
 Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
Dren Bio, Inc.
 Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Sofinnova Ventures |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
